Exploring the Glycosylation of Serum CA125

Exploring the Glycosylation of Serum CA125

Ovarian cancer is the most lethal gynaecologic cancer affecting women. The most widely used biomarker for ovarian cancer, CA125, lacks sensitivity and specificity. Here, we explored differences in glycosylation of CA125 between serum from patients with ovarian cancer and healthy controls. We found d...

Full description

Bibliographic Details
Main Authors: Pauline M. Rudd, Michael J. Duffy, Giuliano Elia, Weston B. Struwe, Kieran Wynne, Radka Saldova
Format: Article
Language:English
Published: MDPI AG 2013-07-01
Series:International Journal of Molecular Sciences
Subjects:
CA125
N-glycosylation
biomarker
ovarian cancer
Online Access:http://www.mdpi.com/1422-0067/14/8/15636

Internet

http://www.mdpi.com/1422-0067/14/8/15636

Similar Items